(VOVWORLD) - Pfizer and German partner BioNTech said on Thursday that their vaccine to prevent flu and COVID-19 generated a strong immune response against strains of the viruses in an early...
(VOVWORLD) - Pfizer on Wednesday said it will set the US price for its COVID-19 antiviral treatment Paxlovid at nearly 1,400 USD per five-day course when it moves to...
(VOVWORLD) - Pfizer said on Thursday data from late-stage trials showed its experimental combination of antibiotics was effective in treating deadly infections caused by drug-resistant bacteria
(VOVWORLD) - Pfizer and Clear Creek Bio on Tuesday announced a collaboration to identify a potential drug candidate and develop a new class of oral treatment against COVID-19, as Pfizer...
(VOVWORLD) - People at high risk of severe disease who have yet to get a second COVID-19 booster should not wait for next-generation, Omicron-targeted vaccines expected in the fall...
(VOVWORLD) - Pfizer said on Thursday it is seeking full U.S. approval for its oral COVID-19 antiviral treatment Paxlovid, which is currently available under an emergency use authorization (EUA)
(VOVWORLD) - Pfizer will make all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance available at a not-for-profit price to 45 of...
(VOVWORLD) - Thirty five generic drugmakers around the world will make cheap versions of Pfizer’s highly effective COVID-19 oral antiviral Paxlovid to supply the treatment in 95 poorer countries, the UN...
(VOVWORLD) - Prime Minister Pham Minh Chinh held phone talks with Albert Bourla, CEO of Pfizer in Hanoi on Tuesday evening. This is the second talks between the Vietnamese Government...
(VOVWORLD) - Merck and partner Ridgeback Biotherapeutics said on Friday six lab studies showed their experimental oral COVID-19 drug molnupiravir was active against the fast-spreading Omicron variant
(VOVWORLD) - Israeli researchers said on Saturday they found that a three-shot course of the Pfizer/BioNTech COVID-19 vaccine provided significant protection against the new Omicron variant
(VOVWORLD) - The FDA has given emergency authorization for the use of the Pfizer COVID-19 vaccine in children aged five to 11 years old, setting the stage for a mass...
(VOVWORLD) -The Pfizer vaccine (Comirnaty) will be used to inoculate children aged 12 to 17 nationwide, starting in November, Minister of Health Nguyen Thanh Long said on Tuesday
(VOVWORLD) - The Pfizer/BioNTech COVID-19 vaccine is highly effective at preventing infection and symptomatic disease from the Delta variant among 12- to 18-year-olds, research conducted in Israel...
(VOVWORLD) - A booster dose of the COVID-19 vaccine developed by Pfizer and German partner BioNTech restored efficacy to 95.6% against the virus, including the Delta variant, data released...
(VOVWORLD) - Vietnamese Ambassador to the US Ha Kim Ngoc has proposed that Pfizer, one of the world's leading pharmaceutical and biotechnology companies, cooperate with Vietnam in the production of...
(VOVWORLD) - Pfizer Inc. and BioNTech SE on Friday asked US regulators to authorize their COVID-19 vaccine for emergency use in children aged 5-11
(VOVWORLD) - People who got Johnson & Johnson COVID-19 vaccine as a first shot had a stronger immune response when boosted with vaccines from Pfizer/BioNTech or Moderna, a study...
(VOVWORLD) - Pfizer and BioNTech have asked US regulators to authorize emergency use of their COVID-19 vaccine for children ages 5 to 11, Pfizer said on Thursday
(VOVWORLD) - The Foreign Ministry held a ceremony in Hanoi on Monday to announce the reception of 1.5 million doses of Pfizer/BioNTech COVID-19 vaccine from the COVAX Facility,...